Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ASTM-AASTROM BIOSCIENCES: STEM CELL RESEARCH -- Ignore unavailable to you. Want to Upgrade?

To: Paul A who wrote (106)	12/9/1998 7:56:00 PM
From: Bo Didley	Read Replies (3) \| Respond to of 1084

"ASTOUNDING LIFESAVING TECHNOLOGY" per NBC They did a report on a little girl who had the technology used on her to cure CANCER. No one had to go through a painful bone marrow harvesting to acquire stem cells. Plus they don't have to find a blood match cause stem cells are generic. Finding a match by the old way-- rejection is a problem. No problemo for ASTM. ASTM technology has no autoimmune rejection ! ! ! ! ! ! ASTM's technology was used. IT SAVES LIVES. No mention of the company's name, but it gave a lead for curious people to start searching...like they had to search for GERN, when it's name was not mentioned. GERN ended up gapping from $10 to $23. ASTM is going to the CANCER CONFERANCE this WEEK ! They will be the "hot stock" everyone is talking about, along with the innovative technology for stem cells. Cancer Conferance begins Dec. 12. It will obviously gap. What will keep it going are the other news coverage it will get by newspapers. It has NEWS APPEAL. It also has the "unknown" factor of what will happen at the Cancer Conferance. People will buy it for that unknown Positive factor. bo